Agency Forms Undergoing Paperwork Reduction Act Review, 64228-64229 [E7-22314]

Download as PDF 64228 Federal Register / Vol. 72, No. 220 / Thursday, November 15, 2007 / Notices registered attendees badges that must be worn at all times and returned to security prior to exiting the Cohen Building. Registration questions may be directed to Experient at PAguidelines@experient-inc.com (email), (703) 525–8333 x3346 (phone) or (703) 525–8557 (fax). Dated: November 8, 2007. Penelope Slade Royall, RADM, USPHS, Deputy Assistant Secretary for Health, Office of Disease Prevention and Health Promotion. [FR Doc. E7–22333 Filed 11–14–07; 8:45 am] BILLING CODE 4150–32–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [30Day–08–05AJ] Agency Forms Undergoing Paperwork Reduction Act Review The Centers for Disease Control and Prevention (CDC) publishes a list of information collection requests under review by the Office of Management and Budget (OMB) in compliance with the Paperwork Reduction Act (44 U.S.C. Chapter 35). To request a copy of these requests, call the CDC Reports Clearance Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of Management and Budget, Washington, DC or by fax to (202) 395–6974. Written comments should be received within 30 days of this notice. Proposed Project National Surveillance for Severe Adverse Events Associated with Treatment of Latent Tuberculosis Infection—New, Division of Tuberculosis Elimination (DTBE), National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHSTP), Centers for Disease Control and Prevention (CDC). Background and Brief Description Between October 2000 and October 2007, 79 patients receiving treatment for Latent TB Infection (LTBI) were reported to the Division of Tuberculosis Elimination (DTBE), Centers for Disease Control and Prevention (CDC) with severe adverse events to their medications(s). A severe adverse event is defined as a drug-related reaction resulting in hospitalization or death of a person receiving treatment for LTBI. Deaths reported among persons with LTBI included, 2 of 50 persons who were on the recommended two-month regimen of rifampin and pyrazinamide (RZ); 9 of 22 treated with isoniazid alone, and 2 of 3 patients on other regimens (e.g., pyrazinamide and ethambutol). Severe adverse events such as hospitalizations, liver transplants, and death related to treatment of LTBI continue to be reported to DTBE. The purpose of this information collection request is to determine the annual number and trends of severe adverse events associated with treatment of LTBI and identify common characteristics of patients with severe adverse events during treatment of LTBI. Potential correspondents are any of the 60 reporting areas for the national TB surveillance system (the 50 states, the District of Columbia, New York City, Puerto Rico, and 8 jurisdictions in the Pacific and Caribbean). Data will be collected using the data collection form for adverse event associated with LTBI treatment (AELT). The AELT form is completed for each reported hospitalization or death related to treatment of LTBI and contains demographic, clinical, and laboratory information. CDC will analyze and periodically publish reports summarizing national LTBI treatment adverse events statistics and also will conduct special analyses for publication in peer-reviewed scientific journals to further describe and interpret these data. The Food and Drug Administration (FDA) collects data on adverse events related to drugs through the FDA MedWatch Program but it does not include the disease context and risk factors that are essential for revising treatment options for LTBI. Reporting will be conducted through telephone, email, or during CDC site visits. There is no cost to respondents other than their time to gather medical records to complete the form. The total estimated annualized burden hours are 32. ESTIMATED ANNUALIZED BURDEN Type of respondent Physician ........................................................................... Nurses ............................................................................... Medical Clerk .................................................................... Number of respondents Form name AELT .......................... AELT .......................... AELT .......................... 4 4 4 Dated: November 6, 2007. Maryam I. Daneshvar, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. E7–22308 Filed 11–14–07; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4163–18–P [30Day–08–07AU] Centers for Disease Control and Prevention pwalker on PROD1PC71 with NOTICES Agency Forms Undergoing Paperwork Reduction Act Review The Centers for Disease Control and Prevention (CDC) publishes a list of information collection requests under review by the Office of Management and Budget (OMB) in compliance with the Paperwork Reduction Act (44 U.S.C. Chapter 35). To request a copy of these VerDate Aug<31>2005 19:50 Nov 14, 2007 Jkt 214001 PO 00000 Frm 00038 Fmt 4703 Sfmt 4703 Number reponses per respondent Average burden per response (in hours) 1 1 1 3 4 1 requests, call the CDC Reports Clearance Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of Management and Budget, Washington, DC or by fax to (202) 395–6974. Written comments should be received within 30 days of this notice. Proposed Project Methicillin-Resistant Staphylococcus aureus (MRSA) Infection Control Practices Survey—New—National Center for Preparedness, Detection, and Control of Infectious Diseases (NCPDCID), Centers for Disease Control and Prevention (CDC). E:\FR\FM\15NON1.SGM 15NON1 64229 Federal Register / Vol. 72, No. 220 / Thursday, November 15, 2007 / Notices Background and Brief Description In October, 2006, CDC recommended specific strategies to reduce transmission of multi-drug resistant organisms, including MRSA, in U.S. hospitals. Currently detailed data on ongoing MRSA prevention efforts at hospitals reporting to CDC surveillance systems is unknown. CDC has developed a survey to assess MRSA prevention programs in place at health care facilities reporting MRSA infection data to CDC through established surveillance systems. In this project, infection control practitioners in all hospitals that participate in the MRSA portion of the Active Bacterial Core Surveillance System will be surveyed electronically three times. There will be an initial baseline survey and then two follow-up surveys, each a year apart. The surveys will determine if changes in infection control practice correlate with changes in rates of MRSA infections. The proposed survey will provide data that can be used to assess progress toward achieving CDC’s Health Protection Goals. The survey will also provide data on facility-based MRSA Number of respondents Respondents Infection Control Practitioners ................................................................................... Dated: November 8, 2007. Maryam I. Daneshvar, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. E7–22314 Filed 11–14–07; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [30Day–08–0728] Agency Forms Undergoing Paperwork Reduction Act Review The Centers for Disease Control and Prevention (CDC) publishes a list of information collection requests under review by the Office of Management and Budget (OMB) in compliance with the Paperwork Reduction Act (44 U.S.C. Chapter 35). To request a copy of these requests, call the CDC Reports Clearance Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of Management and Budget, Washington, DC or by fax to (202) 395–6974. Written comments should be received within 30 days of this notice. pwalker on PROD1PC71 with NOTICES Proposed Project The National Electronic Disease Surveillance System (NEDSS)— Extension—National Center for Public Health Informatics (NCPHI), Centers for Disease Control and Prevention (CDC). VerDate Aug<31>2005 19:50 Nov 14, 2007 Jkt 214001 prevention policies and procedures that may affect MRSA infection rates. These results will inform CDC in the prevention and control of MRSA. This proposed project supports CDC’s Goal of ‘‘Healthy People in Healthy Places’’ and its Strategic Goal to ‘‘Increase the number of health care institutions that comply with evidence based guidelines for infection control.’’ There is no cost to respondents other than their time to complete the survey. The total estimated annualized burden hours are 105 hours. 210 Background and Brief Description CDC is responsible for the dissemination of nationally notifiable diseases information and for monitoring and reporting the impact of epidemic influenza on mortality, Public Health Services Act (42 U.S.C. 241). Since April 1984, CDC Epidemiology Program Office (EPO) has been working with the Council of State and Territorial Epidemiologists (CSTE) to demonstrate the efficiency and effectiveness of computer transmission of surveillance data between CDC and the state health departments. By 1989, all 50 states were using this computerized disease surveillance system, which was then renamed the National Electronic Telecommunications System for Surveillance (NETSS) to reflect its national scope (OMB numbers 0920– 0447 and 0920–0007). Beginning in 1999, CDC, Epidemiology Program Office (EPO) worked with CSTE, state and local public health system staff, and other CDC disease prevention and control program staff to identify information categories and information technology standards to support integrated disease surveillance. That effort is now focused on development and completion of the National Electronic Disease Surveillance System (NEDSS), coordinated by CDC’s National Center for Public Health Informatics, Division of Integrated Surveillance Systems and Services (DISSS). States will continue to use portions of NETSS to transmit data to CDC. One of PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 Number of responses per respondent Average burden per response (in hours) 1 30/60 the reasons for providing NETSS to NEDSS data mapping is to identify what data elements in NETSS correspond to data elements in NEDSS. Those elements mapped from NETSS to NEDSS were collected in OMB number 0920–0007. NEDSS will electronically integrate and link together a wide variety of surveillance activities and will facilitate more accurate and timely reporting of disease information to CDC and state and local health departments. Consistent with recommendations supported by our state and local surveillance partners and described in the 1995 report, Integrating Public Health Information and Surveillance Systems, NEDSS includes data standards, an internet based communications infrastructure built on industry standards, and policy-level agreements on data access, sharing, burden reduction, and protection of confidentiality. To support NEDSS, CDC has developed an information system, the NEDSS Base System (NBS), which uses NEDSS technical and information standards. The NBS is currently deployed to 16 states, including AL, AR, ID, MD, ME, MT, NE, NM, NV, RI, SC, TN, TX, VA, VT, and WY. CDC is requesting a three-year OMB clearance extension of collecting the NEDSS data. There are no costs to respondents other than their time. The average total annualized burden for the Weekly Morbidity Reports and the Annual Summary Report is 9,384 hours. E:\FR\FM\15NON1.SGM 15NON1

Agencies

[Federal Register Volume 72, Number 220 (Thursday, November 15, 2007)]
[Notices]
[Pages 64228-64229]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-22314]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-08-07AU]


Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) publishes a 
list of information collection requests under review by the Office of 
Management and Budget (OMB) in compliance with the Paperwork Reduction 
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call 
the CDC Reports Clearance Officer at (404) 639-5960 or send an e-mail 
to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of 
Management and Budget, Washington, DC or by fax to (202) 395-6974. 
Written comments should be received within 30 days of this notice.

Proposed Project

    Methicillin-Resistant Staphylococcus aureus (MRSA) Infection 
Control Practices Survey--New--National Center for Preparedness, 
Detection, and Control of Infectious Diseases (NCPDCID), Centers for 
Disease Control and Prevention (CDC).

[[Page 64229]]

Background and Brief Description

    In October, 2006, CDC recommended specific strategies to reduce 
transmission of multi-drug resistant organisms, including MRSA, in U.S. 
hospitals. Currently detailed data on ongoing MRSA prevention efforts 
at hospitals reporting to CDC surveillance systems is unknown. CDC has 
developed a survey to assess MRSA prevention programs in place at 
health care facilities reporting MRSA infection data to CDC through 
established surveillance systems. In this project, infection control 
practitioners in all hospitals that participate in the MRSA portion of 
the Active Bacterial Core Surveillance System will be surveyed 
electronically three times. There will be an initial baseline survey 
and then two follow-up surveys, each a year apart. The surveys will 
determine if changes in infection control practice correlate with 
changes in rates of MRSA infections. The proposed survey will provide 
data that can be used to assess progress toward achieving CDC's Health 
Protection Goals. The survey will also provide data on facility-based 
MRSA prevention policies and procedures that may affect MRSA infection 
rates. These results will inform CDC in the prevention and control of 
MRSA.
    This proposed project supports CDC's Goal of ``Healthy People in 
Healthy Places'' and its Strategic Goal to ``Increase the number of 
health care institutions that comply with evidence based guidelines for 
infection control.''
    There is no cost to respondents other than their time to complete 
the survey. The total estimated annualized burden hours are 105 hours.

----------------------------------------------------------------------------------------------------------------
                                                                                Number of        Average burden
                      Respondents                            Number of        responses per    per response  (in
                                                            respondents         respondent           hours)
----------------------------------------------------------------------------------------------------------------
Infection Control Practitioners........................                210                  1              30/60
----------------------------------------------------------------------------------------------------------------


    Dated: November 8, 2007.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for Disease Control and 
Prevention.
[FR Doc. E7-22314 Filed 11-14-07; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.